The Australian Australian and Autoimmune Biobank Collaborative

Certification Status: Complete Education
Registration Status: Completed
Objective:

VISION: The A3BC vision is to identify causes and cures for a wide range of inflammatory arthritic and autoimmune conditions using biobank-enabled, data-linked, collaborative, and multidisciplinary research. The A3BC will identify the biological/environmental causes and phenotypic consequences of musculoskeletal conditions, and combine these with a broad range of patient and population health datasets, to uncover unknown patterns and associations for safer, more effective and evidence-based prevention, diagnosis, treatment and prognosis strategy. The initial scope of A3BC research is to better understand biological and environmental risk factors in RA, JIA, PsA and AS. Once the A3BC has established these diseases within national operations, additional conditions such as Vasculitis, Sjogren's Syndrome, Lower Back Pain, Gout, Scleroderma and Osteoarthritis are intended for future collection, with operational maturity.

Registered Biobank Name The Australian Australian and Autoimmune Biobank Collaborative (A3BC)
Biobank Leader Craig Willers
Principal Investigator LYN MARCH, C Jackson, M Xue, G Hassett, D Singh-Grewal, B Richards, M Lassere, P Youssef, I Lim, J Munro, J Ellis, H Keen, P Walsh, H Benham, R Thomas, M Brown, T Kenna, N Adib, C Barrett, J Ng, C Hill, M Wechalekar, M Rischmueller, C Boros, et al (+3)
Address National network so multiple addresses. NSW HQ: The Institute of Bone and Joint Research (IBJR) Department of Rheumatology Clinical Administration, Level 7 Royal North Shore Hospital St Leonards NSW
Sydney, NSW, Australia
Website https://a3bc.com.au
Email for biobank inquiries info@a3bc.com.au
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: